Computer-Conceived Chemical Compounds Make A Debut

The fledgling field of computer drug design, viewed skeptically by some scientists, gained dramatic validation when scientists from Agouron Pharmaceuticals Inc. reported at a March 18 cancer symposium in Amsterdam that they have created a new compound. Agouron claims the compound, dubbed AG-331, demonstrates "significant anti-tumor activity" in animal tests. "This is a completely novel chemical entity that was not found in nature," says Mike Varney, a computational chemist at San Diego-based

Written byTom Abate
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

"This is a completely novel chemical entity that was not found in nature," says Mike Varney, a computational chemist at San Diego-based Agouron. "It is not a biotechnology product. It is not a product cloned or screened. We truly built it, atom by atom."

The study of how the shapes of molecules influence their propensity to react is an interdisciplinary field sometimes called molecular recognition. Working under this broad heading are structural and cell biologists; computer scientists; and theoretical, experimental, and computational chemists. Computational chemists owe much of their progress in developing software for modeling molecules to the seminal work of Nobel laureate Donald Cram, who in the early 1970s began making models of molecules with the only tools then available--hand-held models in which balls depicted the atoms and sticks represented the bonds between them. After synthesizing the molecules conceived in this fashion, Cram then reacted them with a target ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Unraveling Complex Biology with Advanced Multiomics Technology

Unraveling Complex Biology with Five-Dimensional Multiomics

Element Bioscience Logo
Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Twist Bio 
The Scientist Placeholder Image

Seeing and Sorting with Confidence

BD

Products

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

agilent-logo

Agilent Announces the Enhanced 8850 Gas Chromatograph

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies